Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline...
Executive Accountability: Eric Benjamin Sold $3.7 Million in Insulet Stock Before Two Medical Device Corrections Allegedly Revealed Previously Undisclosed Manufacturing Deficiencies
Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections...
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who...
NEW YORK , July 7, 2026 /PRNewswire/ --
A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet’s Omnipod products.
Law Offices of Howard G. Smith reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Insulet...
LOS ANGELES , July 7, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation ("Insulet"...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ:PODD)...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options